Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the ASX, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

A woman is excited as she reads the latest rumour on her phone.

Image source: Getty Images

AGL Energy Limited (ASX: AGL)

According to a note out of UBS, its analysts have retained their buy rating on this energy giant's shares with a trimmed price target of $11.25. This follows the release of a first half result that was well ahead of the broker's expectations. UBS sees scope for further earnings outperformance in the coming years if its generation availability can be maintained. The AGL share price is trading at $8.72 on Monday.

News Corp (ASX: NWS)

Another note out of UBS reveals that its analysts have retained their buy rating on this media company's shares with an improved price target of $50.40. The broker was pleased with the company's performance during the December quarter and expects more of the same in the future thanks to its digital business. So, with its shares trading on lower than average multiples, it feels that now is a good time to invest. The News Corp share price is fetching $41.81 this afternoon.

Pro Medicus Limited (ASX: PME)

Analysts at Macquarie have initiated coverage on this health imaging technology company's shares with an outperform rating and $120.00 price target. The broker has been looking at the company's prospects in the US market. It believes Pro Medicus could grow its market share from 7% today to 15% in 2030 and 25% in FY 2035. This follows customer feedback that highlights that its Visage 7 software is faster and more efficient than the competition, The Pro Medicus share price is trading at $108.89 on Monday.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Pro Medicus. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A smiling woman holds a Facebook like sign above her head.
Broker Notes

5 ASX shares scoring upgraded ratings this week

Experts have raised their ratings on JB Hi-Fi, Beach Energy, Amcor, and others this week.

Read more »

A man sitting at his dining table looks at his laptop and ponders the share price.
Broker Notes

Down 65%: Is this ASX 300 stock a cheap buy?

This stock has been sold off. Has this created a buying opportunity? Let's see what Bell Potter is saying.

Read more »

Three guys in shirts and ties give the thumbs down.
Broker Notes

5 ASX All Ords shares downgraded by brokers this week

Brokers have reduced their ratings on PLS Group, Fortescue, Webjet, and others this week.

Read more »

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.
Broker Notes

Does Ord Minnett rate Goodman shares as a buy, hold, or sell?

The broker has been looking at a big agreement signed this month.

Read more »

Red sell button on an Apple keyboard.
Broker Notes

Sell alert! Why this expert is calling time on Westpac shares

A leading analyst delivers his verdict on Westpac shares.

Read more »

A woman wearing a black and white striped t-shirt looks to the sky with her hand to her chin, contemplating buying ASX shares.
Broker Notes

Buy, hold, sell: Minerals 260, 4DMedical, Karoon Energy shares

Two experts share their latest ratings and opinions on three ASX shares.

Read more »

Two mining workers in orange high vis vests walk and talk at a mining site.
Resources Shares

Morgans tips 1 ASX mining share to rip — and 1 to avoid — in 2026

Morgans has revised its ratings on an ASX 200 lithium share and an ASX 200 gold stock.

Read more »

Woman and man calculating a dividend yield.
Broker Notes

What is Morgans saying about Stanmore Resources and Suncorp shares after results?

Are these shares a buy, hold, or sell?

Read more »